Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features

Journal of Pathology

Volumn 211, Issue 3, 2007, Pages 269-277

  Cho, N Y ^a   Kim, B H ^a   Choi, M ^a   Yoo, E J ^a   Moon, K C ^a   Cho, Y M ^b   Kim, D ^c   Kang, G H ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

CpG island; DNA methylation; Hypomethylation; Prostate adenocarcinoma

Indexed keywords

AMINO ACID TRANSPORTER; APC PROTEIN; BISULFITE; CELLULAR RETINOL BINDING PROTEIN 1; CYCLOOXYGENASE 2; DNA; GLUTATHIONE TRANSFERASE P1; HERMES ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; NEUROGENIC DIFFERENTIATION FACTOR; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PROTEIN P16; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR RUNX3; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DISEASE COURSE; DNA METHYLATION; GENE LOCUS; GENETIC ASSOCIATION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; TISSUE TYPES; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; ALU ELEMENTS; CPG ISLANDS; DNA; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 33846639662     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2106     Document Type: Article

References (35)

1. Yip I, Heber D, Aronson W. Nutrition and prostate cancer. Urol Clin North Am 1999;26:403-411.
2. Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003;30:209-217.
3. Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-864.
4. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-381.
5. Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zochbauer-Muller S, Farinas AJ, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002;8:514-519.
6. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004;64:1975-1986.
7. Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 2004;202:233-240.
8. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55:5195-5199.
9. Bastian PJ, Yegnasubramanian S, Palapattu GS, Rogers CG, Lin X, De Marzo AM, et al. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. Eur Urol 2004;46:698-708.
10. Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Muller SC, et al. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res 2005;11:4097-4106.
11. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, et al. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res 2005;11:6582-6588.
12. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-492.
13. Karpf AR, Matsui S. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 2005;65:8635-8639.
14. Bedford MT, van Helden PD. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 1987;47:5274-5276.
15. Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA. High frequency of alterations in DNA methyation in adenocarcinorna of the prostate. Prostate 1999;39:166-174.
16. Florl AR, Steinhoff C, Muller M, Seifert HH, Hader C, Engers R, et al. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer 2004;91:985-994.
17. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
18. Jordan IK, Rogozin IB, Glazko GV, Koonin EV. Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet 2003;19:68-72.
19. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science 2004;303:1626-1632.
20. Kochanek S, Renz D, Doerfler W. DNA methylation in the Alu sequences of diploid and haploid primary human cells. EMBO J 1993;12:1141-1151.
21. Kaneda A, Tsukamoto T, Takamura-Enya T, Watanabe N, Kaminishi M, Sugimura T, et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 2004;95:58-64.
22. Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, Campan M, et al. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene 2006;25:2836-2845.
23. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005;33:6823-6836.
24. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
25. Hermanek P, Hurter RVP, Sobin LH, Spiessi B, Wagner G, eds. TNM Atlas, Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors (4th edn). Springer-Verlag: Heidelberg, 1997.
26. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002;160:787-794.
27. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004;23:8841-8846.
28. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004;32:e38.
29. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002;21:5400-5413.
30. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006;9:199-207.
31. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 2003;162:1361-1371.
32. Cravo M, Pinto R, Fidalgo P, Chaves P, Gloria L, Nobre-Leitao C, et al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 1996;39:434-438.
33. Schulz WA, Elo JP, Florl AR, Permanen S, Santourlidis S, Engers R, et al. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 2002;35:58-65.
34. Jeronimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004;10:8472-8478.
35. Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, Takahashi H, et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003;106:382-387.